Author Correction: Preclinical and clinical characterization of the RORγt inhibitor JNJ-61803534
Sci Rep
.
2022 Apr 6;12(1):5740.
doi: 10.1038/s41598-022-09558-2.
Authors
Xiaohua Xue
1
,
Aimee De Leon-Tabaldo
2
,
Rosa Luna-Roman
2
,
Glenda Castro
3
,
Michael Albers
4
,
Freddy Schoetens
2
,
Samuel DePrimo
2
,
Damayanthi Devineni
3
,
Thomas Wilde
3
,
Steve Goldberg
2
,
Olaf Kinzel
4
,
Thomas Hoffmann
4
,
Anne M Fourie
2
,
Robin L Thurmond
5
Affiliations
1
Janssen Research & Development, LLC, La Jolla, CA, USA.
[email protected]
.
2
Janssen Research & Development, LLC, La Jolla, CA, USA.
3
Janssen Research & Development, LLC, Spring House, PA, USA.
4
Department of Research, Phenex Pharmaceuticals AG, Heidelberg, Germany.
5
Janssen Research & Development, LLC, La Jolla, CA, USA.
[email protected]
.
PMID:
35388049
PMCID:
PMC8987041
DOI:
10.1038/s41598-022-09558-2
No abstract available
Publication types
Published Erratum